{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-017118","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.757556+00:00","generated_at":"2026-05-16T02:05:30.953774+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"confidence":"high","headline":"Outlook Therapeutics receives Nasdaq minimum bid price deficiency notice; 180-day cure period","bullets":["Received Nasdaq letter on Feb 18, 2026, for closing bid price below $1.00 for 30 consecutive business days.","Has 180 calendar days, until August 17, 2026, to regain compliance.","To regain compliance, bid price must close at $1.00+ for at least 10 consecutive business days.","If not compliant by Aug 17, may be eligible for additional 180-day period if it meets other standards.","Company will monitor bid price and evaluate options including reverse stock split."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-017118","json":"https://secwatch.observer/filing/0001104659-26-017118.json","markdown":"https://secwatch.observer/filing/0001104659-26-017118.md","text":"https://secwatch.observer/filing/0001104659-26-017118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926017118/0001104659-26-017118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926017118/tm266772d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:05:30.953774+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}